176 related articles for article (PubMed ID: 9465093)
1. Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo.
Martin WH; Hoover DJ; Armento SJ; Stock IA; McPherson RK; Danley DE; Stevenson RW; Barrett EJ; Treadway JL
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1776-81. PubMed ID: 9465093
[TBL] [Abstract][Full Text] [Related]
2. The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors.
Andersen B; Westergaard N
Biochem J; 2002 Oct; 367(Pt 2):443-50. PubMed ID: 12099891
[TBL] [Abstract][Full Text] [Related]
3. Indole-2-carboxamide inhibitors of human liver glycogen phosphorylase.
Hoover DJ; Lefkowitz-Snow S; Burgess-Henry JL; Martin WH; Armento SJ; Stock IA; McPherson RK; Genereux PE; Gibbs EM; Treadway JL
J Med Chem; 1998 Jul; 41(16):2934-8. PubMed ID: 9685232
[No Abstract] [Full Text] [Related]
4. Kinetic and functional characterization of 1,4-dideoxy-1, 4-imino-d-arabinitol: a potent inhibitor of glycogen phosphorylase with anti-hyperglyceamic effect in ob/ob mice.
Fosgerau K; Westergaard N; Quistorff B; Grunnet N; Kristiansen M; Lundgren K
Arch Biochem Biophys; 2000 Aug; 380(2):274-84. PubMed ID: 10933882
[TBL] [Abstract][Full Text] [Related]
5. Dual-action hypoglycemic and hypocholesterolemic agents that inhibit glycogen phosphorylase and lanosterol demethylase.
Harwood HJ; Petras SF; Hoover DJ; Mankowski DC; Soliman VF; Sugarman ED; Hulin B; Kwon Y; Gibbs EM; Mayne JT; Treadway JL
J Lipid Res; 2005 Mar; 46(3):547-63. PubMed ID: 15604516
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 5-chloro-N-aryl-1H-indole-2-carboxamide derivatives as inhibitors of human liver glycogen phosphorylase a.
Onda K; Suzuki T; Shiraki R; Yonetoku Y; Negoro K; Momose K; Katayama N; Orita M; Yamaguchi T; Ohta M; Tsukamoto S
Bioorg Med Chem; 2008 May; 16(10):5452-64. PubMed ID: 18434170
[TBL] [Abstract][Full Text] [Related]
7. Endogenous effectors of human liver glycogen phosphorylase modulate effects of indole-site inhibitors.
Ercan-Fang N; Taylor MR; Treadway JL; Levy CB; Genereux PE; Gibbs EM; Rath VL; Kwon Y; Gannon MC; Nuttall FQ
Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E366-72. PubMed ID: 15797986
[TBL] [Abstract][Full Text] [Related]
8. Hepatic glycogen synthesis is highly sensitive to phosphorylase activity: evidence from metabolic control analysis.
Aiston S; Hampson L; Gómez-Foix AM; Guinovart JJ; Agius L
J Biol Chem; 2001 Jun; 276(26):23858-66. PubMed ID: 11309391
[TBL] [Abstract][Full Text] [Related]
9. Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-R*,S*]-5-chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1H-indole-2-carboxamide).
Suh SW; Bergher JP; Anderson CM; Treadway JL; Fosgerau K; Swanson RA
J Pharmacol Exp Ther; 2007 Apr; 321(1):45-50. PubMed ID: 17251391
[TBL] [Abstract][Full Text] [Related]
10. Diverse effects of two allosteric inhibitors on the phosphorylation state of glycogen phosphorylase in hepatocytes.
Latsis T; Andersen B; Agius L
Biochem J; 2002 Nov; 368(Pt 1):309-16. PubMed ID: 12186629
[TBL] [Abstract][Full Text] [Related]
11. Glutathione-dependent reduction of arsenate by glycogen phosphorylase responsiveness to endogenous and xenobiotic inhibitors.
Gregus Z; Németi B
Toxicol Sci; 2007 Nov; 100(1):44-53. PubMed ID: 17693424
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid and amino acid modulation of glucose cycling in isolated rat hepatocytes.
Gustafson LA; Neeft M; Reijngoud DJ; Kuipers F; Sauerwein HP; Romijn JA; Herling AW; Burger HJ; Meijer AJ
Biochem J; 2001 Sep; 358(Pt 3):665-71. PubMed ID: 11535127
[TBL] [Abstract][Full Text] [Related]
13. Contributions of hepatic gluconeogenesis suppression and compensative glycogenolysis on the glucose-lowering effect of CS-917, a fructose 1,6-bisphosphatase inhibitor, in non-obese type 2 diabetes Goto-Kakizaki rats.
Yoshida T; Okuno A; Takahashi K; Ogawa J; Hagisawa Y; Kanda S; Fujiwara T
J Pharmacol Sci; 2011; 115(3):329-35. PubMed ID: 21350313
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors.
Onda K; Shiraki R; Ogiyama T; Yokoyama K; Momose K; Katayama N; Orita M; Yamaguchi T; Furutani M; Hamada N; Takeuchi M; Okada M; Ohta M; Tsukamoto S
Bioorg Med Chem; 2008 Dec; 16(23):10001-12. PubMed ID: 18952447
[TBL] [Abstract][Full Text] [Related]
15. Regulation of glycogen metabolism in cultured human muscles by the glycogen phosphorylase inhibitor CP-91149.
Lerín C; Montell E; Nolasco T; García-Rocha M; Guinovart JJ; Gómez-Foix AM
Biochem J; 2004 Mar; 378(Pt 3):1073-7. PubMed ID: 14651477
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and anti-hyperglycaemic efficacy of a novel inhibitor of glycogen phosphorylase, 1,4-dideoxy-1,4-imino-d- arabinitol, in glucagon-challenged rats and dogs and in diabetic ob/ob mice.
Mackay P; Ynddal L; Andersen JV; McCormack JG
Diabetes Obes Metab; 2003 Nov; 5(6):397-407. PubMed ID: 14617225
[TBL] [Abstract][Full Text] [Related]
17. Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus.
Treadway JL; Mendys P; Hoover DJ
Expert Opin Investig Drugs; 2001 Mar; 10(3):439-54. PubMed ID: 11227044
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of glycogenolysis in isolated hepatocytes by adenosine and one of its analogues is inhibited by caffeine.
Stanley JC; Markovic J; Gutknecht AM; Lozeman FJ
Biochem J; 1987 Nov; 247(3):779-83. PubMed ID: 3426562
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of glycogen synthesis and inactivation of phosphorylase in hepatocytes by serotonergic mechanisms, and counter-regulation by atypical antipsychotic drugs.
Hampson LJ; Mackin P; Agius L
Diabetologia; 2007 Aug; 50(8):1743-51. PubMed ID: 17579833
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation state of the enzyme.
Freeman S; Bartlett JB; Convey G; Hardern I; Teague JL; Loxham SJ; Allen JM; Poucher SM; Charles AD
Br J Pharmacol; 2006 Nov; 149(6):775-85. PubMed ID: 17016495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
